Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transnasal sphenopalatine block with lidocaine for post-dural puncture headache after spinal anesthesia
IRCT20200501047254N4Phase 3Completed
- Sponsor
- Gonabad University of Medical Sciences
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of lidocaine in post-dural puncture headache (PDPH) (2 arms), sponsored by Gonabad University of Medical Sciences. Primary endpoint: Headache reduction. Started Sep 2025; status: completed.
02
Drugs
lidocaine
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on IRCT20200501047254N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200501047254N4.